A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

The major stock indexes were mixed on Monday, at the outset of another busy week of quarterly earnings reports and the release of key private sector employment data.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion in a deal that would create ...

Kimberly-Clark Corp. agreed to buy Kenvue Inc. for roughly $40 billion, snapping up the embattled Tylenol maker’s storied brands in a gamble that would vault the Kleenex producer into consumer ...

Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while supply of another type of painkiller has increased since a nationwide disruption in ...

As a Kenvue Inc. ( KVUE) shareholder, the core question is whether the proposed acquisition by Kimberly-Clark Corporation ( ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

Consumer goods giant Kimberly-Clark Corp. is buying Tylenol maker Kenvue Inc. in a deal valued at $48.7 billion. Consumer-goods giant Kimberly-Clark Corp. announced Monday a deal to buy Kenvue Inc., ...

2025 hasn't been kind to Kenvue (NYSE: KVUE) stock lately. Shares of the one-time Johnson & Johnson unit got hit hard after ...